Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6182599 | Gynecologic Oncology | 2016 | 10 Pages |
Abstract
PD-L1 is primarily expressed by macrophages in ovarian cancer and is strongly associated with both cytolytic and regulatory TIL subsets, resulting in a net positive association with survival. Tumors containing PD-L1+ macrophages appear caught in an immunological stalemate that may require multi-pronged immunotherapy to alleviate.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
John R. Webb, Katy Milne, David R. Kroeger, Brad H. Nelson,